Back to search
Onchocerciasis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Onchocerciasis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Onchocerciasis trials you may qualify forThis study will evaluate and treat patients with filarial infections to explore in depth the immunology of the disease, including susceptibility to infection, d…
This clinical trial compares two treatments - ivermectin and moxidectin - to learn which is better at reducing the proportion of people with onchocerciasis (riv…
Onchocerciasis, also known as river blindness, is one of the disease targeted for elimination by the World Health Organization (WHO) in the group of Neglected T…
The aim of the study is to evaluate the safety and efficacy of a 3- and 5-day course of levamisole (2.5 mg/kg) in management of loiasis microfilaremia.
Skin-related Neglected Tropical Diseases (Skin NTDs) affect about 1.8 billion people worldwide, particularly in poor and rural communities where healthcare acce…
The purpose of this phase 3b study is to determine the safety of a single dose of moxidectin, compared to a single dose of ivermectin, in individuals living in…